Boston Trust Walden Corp Has $18.15 Million Stake in Teleflex Incorporated (NYSE:TFX)

Boston Trust Walden Corp decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 55.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 131,364 shares of the medical technology company's stock after selling 163,250 shares during the quarter. Boston Trust Walden Corp owned 0.28% of Teleflex worth $18,153,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of TFX. State of Alaska Department of Revenue increased its stake in shares of Teleflex by 386.0% in the first quarter. State of Alaska Department of Revenue now owns 25,734 shares of the medical technology company's stock valued at $3,556,000 after buying an additional 20,439 shares during the period. QRG Capital Management Inc. increased its stake in shares of Teleflex by 35.9% in the first quarter. QRG Capital Management Inc. now owns 2,959 shares of the medical technology company's stock valued at $409,000 after buying an additional 781 shares during the period. Janney Montgomery Scott LLC increased its stake in shares of Teleflex by 5.6% in the first quarter. Janney Montgomery Scott LLC now owns 17,665 shares of the medical technology company's stock valued at $2,441,000 after buying an additional 942 shares during the period. Hengehold Capital Management LLC increased its stake in shares of Teleflex by 147.6% in the first quarter. Hengehold Capital Management LLC now owns 3,191 shares of the medical technology company's stock valued at $441,000 after buying an additional 1,902 shares during the period. Finally, Opal Wealth Advisors LLC acquired a new position in shares of Teleflex in the first quarter valued at approximately $100,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

TFX has been the subject of several recent research reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Royal Bank Of Canada lowered their price objective on Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a research note on Friday, May 2nd. Morgan Stanley lowered their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Wall Street Zen downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Finally, Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and decreased their target price for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, Teleflex has a consensus rating of "Hold" and a consensus target price of $164.63.

Teleflex Stock Performance

NYSE:TFX opened at $117.73 on Friday. The company has a market capitalization of $5.20 billion, a PE ratio of 37.14, a P/E/G ratio of 1.84 and a beta of 1.10. The company has a 50 day simple moving average of $125.67 and a two-hundred day simple moving average of $150.62. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.32 and a current ratio of 2.28. Teleflex Incorporated has a fifty-two week low of $117.04 and a fifty-two week high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The company's revenue for the quarter was down 5.0% compared to the same quarter last year. During the same period in the prior year, the business earned $3.21 EPS. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date was Tuesday, May 20th. Teleflex's payout ratio is 42.90%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.